iA Global Asset Management Inc. Acquires New Stake in Axon Enterprise, Inc. (NASDAQ:AXON)

iA Global Asset Management Inc. acquired a new stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 8,219 shares of the biotechnology company’s stock, valued at approximately $4,885,000.

A number of other hedge funds have also made changes to their positions in the stock. Asset Dedication LLC increased its stake in shares of Axon Enterprise by 11.3% during the fourth quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company’s stock valued at $106,000 after acquiring an additional 18 shares during the period. Bleakley Financial Group LLC grew its position in Axon Enterprise by 1.3% in the fourth quarter. Bleakley Financial Group LLC now owns 1,527 shares of the biotechnology company’s stock worth $908,000 after buying an additional 20 shares during the last quarter. Venturi Wealth Management LLC grew its position in Axon Enterprise by 2.7% in the fourth quarter. Venturi Wealth Management LLC now owns 802 shares of the biotechnology company’s stock worth $477,000 after buying an additional 21 shares during the last quarter. Insigneo Advisory Services LLC grew its position in Axon Enterprise by 1.4% in the third quarter. Insigneo Advisory Services LLC now owns 1,568 shares of the biotechnology company’s stock worth $627,000 after buying an additional 22 shares during the last quarter. Finally, Menard Financial Group LLC grew its position in Axon Enterprise by 0.8% in the third quarter. Menard Financial Group LLC now owns 3,014 shares of the biotechnology company’s stock worth $1,204,000 after buying an additional 24 shares during the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Wall Street Analysts Forecast Growth

AXON has been the topic of several recent research reports. Craig Hallum lowered shares of Axon Enterprise from a “buy” rating to a “cautious” rating in a research report on Monday, March 10th. Robert W. Baird raised their price objective on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. Needham & Company LLC reaffirmed a “buy” rating and issued a $600.00 price objective on shares of Axon Enterprise in a research note on Wednesday, February 26th. TD Cowen initiated coverage on shares of Axon Enterprise in a research note on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price objective for the company. Finally, Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and raised their price objective for the stock from $500.00 to $700.00 in a research note on Tuesday, December 3rd. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have given a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $604.67.

Axon Enterprise Trading Down 1.7 %

Shares of NASDAQ:AXON opened at $558.41 on Friday. The firm has a fifty day moving average of $592.10 and a two-hundred day moving average of $539.60. The firm has a market capitalization of $42.79 billion, a P/E ratio of 144.29, a price-to-earnings-growth ratio of 5.17 and a beta of 1.12. Axon Enterprise, Inc. has a 12-month low of $273.52 and a 12-month high of $715.99. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32.

Insider Activity

In other news, insider Jeffrey C. Kunins sold 1,035 shares of the firm’s stock in a transaction on Monday, December 23rd. The shares were sold at an average price of $624.47, for a total transaction of $646,326.45. Following the transaction, the insider now owns 124,243 shares in the company, valued at approximately $77,586,026.21. This trade represents a 0.83 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Jeri Williams sold 307 shares of the firm’s stock in a transaction on Monday, March 17th. The shares were sold at an average price of $552.72, for a total transaction of $169,685.04. Following the transaction, the director now owns 1,627 shares in the company, valued at $899,275.44. This represents a 15.87 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 1,792 shares of company stock worth $1,087,843. 5.70% of the stock is owned by corporate insiders.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.